SEC FORM 3

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Turenshine Daniella

(Last)

(First)

(Middle)

C/O FIGS, INC. 2834 COLORADO AVENUE

SUITE 100

(Street)

SANTA MONICA

90404

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
12/24/2021

3. Issuer Name and Ticker or Trading Symbol
FIGS, Inc. [ FIGS ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Financial Officer

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Class A Common Stock	39,513⁽¹⁾	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Stock Option (Right to Buy)	⁽²⁾	05/26/2031	Class A Common Stock	50,897	$22	D
Stock Option (Right to Buy)	⁽³⁾	12/26/2030	Class A Common Stock	129,375	$6.0222	D
Stock Option (Right to Buy)	⁽⁴⁾	09/16/2030	Class A Common Stock	38,439	$0.8122	D
Stock Option (Right to Buy)	⁽⁵⁾	10/09/2029	Class A Common Stock	58,131	$0.4589	D
Stock Option (Right to Buy)	⁽⁶⁾	12/12/2028	Class A Common Stock	37,503	$0.4556	D

Explanation of Responses:

1. 6,961 of these securities are Restricted Stock Units ("RSUs"), each representing a contingent right to receive one share of the Issuer's Class A Common Stock. The RSUs vest in equal quarterly installments over the four-year period following June 1, 2021.

2. The original (full) option vests and becomes exercisable in 48 equal monthly installments, with the first installment vesting on July 1, 2021. 6,362 shares underlying the option have vested.

3. The original (full) option vests and becomes exercisable in 48 equal monthly installments, with the first installment vesting on January 31, 2021. 30,933 shares underlying the option have vested.

4. The original (full) option vests and becomes exercisable in 48 equal monthly installments, with the first installment vesting on September 26, 2020. 14,056 shares underlying the option have vested.

5. The original (full) option vests and becomes exercisable in 48 equal monthly installments, with the first installment vesting on October 31, 2019. 48,750 shares underlying the option have vested.

6. The original (full) option vests and becomes exercisable as to 25% of the shares on November 12, 2019, and in 36 equal monthly installments thereafter. 69,375 shares underlying the option have vested.

Remarks:

Table II only lists options held by the Reporting Person that have not yet been exercised. Shares of the Issuer's Class A Common Stock acquired from the exercise of options held by the Reporting Person are reflected in Table I. Exhibit 24 - Power of Attorney

	/s/ Danielle Warner as Attorney-in-Fact for Daniella Turenshine	12/28/2021
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.